ACE and heart failure: A beta-blocker is recommended in addition to an ACE inhibitor for symptomatic patients with HFrEF to reduce the risk of heart failure hospitalization and death [83]; a mineralocorticoid/aldosterone receptor antagonist may be added in those who remain symptomatic despite treatment with a beta-blocker and ACE inhibitor.